Scarica l'app Stockscreener
2.86
0.35%
0.010
Dopo l'orario di chiusura:
2.86
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché AVXL Giù?
Forum
Previsione
Frazionamento azionario
Anavex Life Sciences Corp Borsa (AVXL) Ultime notizie
Anavex Life Sciences (AVXL) Board Shakeup Sparks Pre-Market Inte - GuruFocus
Anavex gains as PVG calls for board reshuffle (AVXL:NASDAQ) - Seeking Alpha
ANAVEX LIFE SCIENCES CORP. SEC Filing (Sep 3, 2026) - Stock Titan
PVG Asset Management Pushes for Board Changes at Anavex Life Sci - GuruFocus
PVG Asset Management targets Anavex (NASDAQ: AVXL) board in 2026 vote push - Stock Titan
Anavex Life Sciences Regains Nasdaq Compliance After Filing Quarterly Reports - marketscreener.com
Anavex Life Sciences regains Nasdaq compliance By Investing.com - Investing.com Nigeria
Anavex Life Sciences regains Nasdaq compliance after filing delayed 10-Qs - TradingView
Anavex Life Sciences regains Nasdaq compliance - Investing.com India
Anavex Life Sciences Regains Compliance with Nasdaq Periodic Filing Requirement - Anavex Life Sciences
Anavex will keep trading on Nasdaq after filing its outstanding reports - Stock Titan
AVXL Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
New proxy contest hits Anavex (AVXL) as PVG presses its case for the 2026 shareholder vote - Stock Titan
PVG Asset Management Corporation Files Definitive Proxy Statement and Launches Shareholder Website in Connection with Anavex Life Sciences Corp.’s 2026 Annual Meeting - The Manila Times
PVG Asset Management Corporation Files Definitive Proxy - GlobeNewswire
Anavex Life Sciences : Amendment to Annual Report (Form 10-K/A) - marketscreener.com
Anavex (AVXL) admits control weakness yet keeps Dec. 2025 numbers - Stock Titan
Anavex: After The EU Said No, The FDA Path Looks Long And Expensive - Seeking Alpha
Anavex Life Sciences Releases Q3 2026 Financial Results - AlphaStreet
Anavex Life Sciences reports Q3 FY2026 net income $7.8M, cash $118.3M - TradingView
Anavex Life Sciences: Fiscal Q3 Earnings Snapshot - KING5.com
Anavex Life Sciences (AVXL) Sees Stock Surge Following Q3 Update and Regulatory Progress - GuruFocus
Anavex (AVXL) Momentum: Moves 7.67% Down to $3.13; Technical Setup: the $2.97 to $3.29 Range Remains in Focus on the DayRetail Volume - Vinanet
PVG mounts six-seat board challenge at Anavex (AVXL) - Stock Titan
Anavex Life Sciences Corp (AVXL) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Anavex Life Sciences Releases Stockholder Letter and Press Release for 2026 Annual Meeting - Kalkine Media
Anavex Urges Shareholders to Back Six Director Nominees Ahead of 2026 Annual Meeting - Yahoo Finance
Form 8K Anavex Life Sciences Corp For: 17 August By Investing.com - Investing.com Canada
Anavex Life Sciences Mails Letter to Stockholders Reinforcing Relevant Experience of All Six Director Nominees - The Manila Times
Six Anavex Director Nominees Face a Sept. 24 Vote—What Sets Them Apart? - Stock Titan
Promising Penny Stocks To Consider In August 2026 - Sahm
(AVXL) Movement Within Algorithmic Entry Frameworks - Stock Traders Daily
Anavex Life Sciences Files Proxy, Urges Director Support - The Globe and Mail
Anavex Life Sciences Corp. (NASDAQ:AVXL) Receives Consensus Rating of "Hold" from Analysts - MarketBeat
Anavex urges shareholders to back board slate amid proxy fight By Investing.com - Investing.com UK
Anavex Life Sciences files definitive proxy, urges vote for six director nominees ahead of Sept. 24 meeting - TradingView
Anavex Life Sciences Faces September Board Vote as Blarcamesine Regulatory Strategy Advances - Yahoo Finance
Anavex urges shareholders to back board slate amid proxy fight - Investing.com
Anavex Life Sciences Highlights Highly Qualified Board and Decisive Actions to Create Long-Term Value for Stockholders - The Manila Times
Anavex Life Sciences Files Definitive Proxy Statement and Urges Stockholders to Vote for All Six Director Nominees on WHITE Card - Quiver Quantitative
Anavex Life Sciences Corp Solicits Proxies from Shareholders - marketscreener.com
Anavex Life Sciences (NASDAQ:AVXL) Stock Crosses Above 50-Day Moving AverageWhat's Next? - MarketBeat
Anavex Life Sciences (NASDAQ: AVXL) delays two 2026 quarterly SEC reports - Stock Titan
AVXL Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
Anavex Life Sciences Corp expected to post a loss of 8 cents a shareEarnings Preview - TradingView
Anavex Life Sciences Corp. (AVXL) Stock Analysis: Exploring a Potential 509% Upside in Biotech - DirectorsTalk Interviews
Anavex Life Sciences Corp. Revenue Breakdown – NASDAQ:AVXL - TradingView
Anavex Life Sciences (NASDAQ:AVXL) Rallies Today on clinical-stage momentum - Kalkine Media
Anavex Life Sciences Announces Plans to Refresh Board to Continue Overseeing Critical Progress and Stockholder Value Creation - anavex.com
Press Release: Anavex Life Sciences Announces Plans to Refresh Board to Continue Overseeing Critical Progress and Stockholder Value Creation - moomoo.com
Weekly Recap: IND filing for blarcamesine and Q2 loss, cash runway - TradingView
[PREC14A] ANAVEX LIFE SCIENCES CORP. Preliminary Contested Proxy Statement - Stock Titan
Vanguard Capital Management (NASDAQ: AVXL) discloses 5.03% beneficial stake in Anavex - Stock Titan
Anavex Life Sciences: Fiscal Q2 Earnings Snapshot - KING5.com
Anavex expects $127M cash to fund operations into 2028 - Stock Titan
Second Circuit Holds that Delayed, Market-Tracking Stock Drop Dooms Loss Causation - Jones Day
Anavex Life Sciences Corp (AVXL) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Anavex Life Sciences Corp (AVXL) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Anavex Life Sciences Corp (AVXL) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
0.86%
0.31%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):